Platelet-Rich Plasma versus Corticosteroid Injections for Facet and Sacroiliac Joint Pain: A Systematic Review and Meta-Analysis with Trial Sequential Analysis

Clicks: 1
ID: 317290
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #47 of 52 articles by views in regional anesthesia and pain medicine

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Facet and sacroiliac joint (SIJ) pathology are common causes of chronic low back pain. Corticosteroid (CS) injections provide short-term relief but limited durability. Platelet-rich plasma (PRP), an autologous biologic, may offer longer-lasting benefit. We performed a systematic review and meta-analysis of randomized and quasi-randomized controlled trials comparing PRP with corticosteroids. Material and Methods PubMed, Cochrane Library, Scopus, Embase, Web of Science, CINAHL Complete, Virtual Health Library, and ScienceDirect were searched up to 21 June 2025. Eligible studies were randomized or quasi-randomized controlled trials comparing intra- or peri-articular PRP with corticosteroids for facet or sacroiliac joint pain. Primary outcome was the mean pain scores changes from baseline to first, third, and sixth months using a scale of 10 scores (0= no pain, and 10= worst pain). Secondary outcome was disability using Oswestry Disability Index (ODI) or Modified ODI (MODQ). Data was pooled using mean difference (MD) for pain scores outcome, and standardized mean difference (SMD) for disability outcome. Random-effects meta-analysis was performed using ‘Meta’ package in R (RStudio version 4.4.3), with subgroup analyses by joint (facet vs SIJ) to facilitate further interpretation. Results Ten randomized and quasi-randomized controlled trials (six facet, and four SIJ) enrolling 392 patients (mean age 47.04 years, 50.6% male) were included. At one month, pain outcomes favored PRP but did not reach statistical significance (MD -0.35, 95% CI -1.30 to 0.60; p = 0.4696; I2 = 90.6%). At three months, PRP significantly reduced pain versus corticosteroids (MD -1.32, 95% CI -2.14 to -0.50; p = 0.0015), with consistent benefit across facet and SIJ subgroups. Superiority persisted at six months (MD -1.70, 95% CI -3.10 to -0.30; P = 0.0171). Disability outcome showed no significant difference at one month (SMD 0.05, 95% CI -0.45 to 0.54), and at three months (SMD -0.63, 95% CI -1.29 to 0.03; P = 0.0613). Conclusion PRP appears to be a promising intervention; however, current evidence remains inconclusive. Available data suggest that PRP may provide superior medium- and long-term pain reduction compared with corticosteroid injections for facet and SIJ, supporting its potential role as a biologic therapy in spinal pain management. Nevertheless, the certainty of this evidence is limited, and further well-designed, adequately powered studies with standardized PRP protocols are required to confirm these findings.
Reference Key
openalex_W7164854874 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dawood Alatefi, Malik Alkabazi, Ahmed Alanzi, Bano Alsaleh, Salsabeel Al Mubaidin, Majed Amro, Mohammad K Nofal, I Gamal, Mikhail Kuzin, Abdulhakim Hezam
Journal regional anesthesia and pain medicine
Year 2026
DOI
10.1093/pm/pnag072
URL
https://doi.org/10.1093/pm/pnag072
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.